Anti-Hu CD64 Purified

Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Dry Ice Shipment: No

Alternative Products

Cat	Name
MBS1800003-02	Anti-Hu CD64 Purified
MBS1800003-01	Anti-Hu CD64 Purified
MBS1800004-02	Anti-Hu CD64 Purified Low Endotoxin
MBS1800004-01	Anti-Hu CD64 Purified Low Endotoxin
M02428	Anti-Hu CD64 Purified FCGR1A Monoclonal Antibody
MBS1800008-02	Anti-Hu CD64 PE
MBS1800005-02	Anti-Hu CD64 APC
MBS1800006-02	Anti-Hu CD64 Biotin
MBS1800007-02	Anti-Hu CD64 FITC
MBS1800008-01	Anti-Hu CD64 PE

CAT:

270-11-644-C025

Size:

0.025 mg

Price:

Ask

For price, please contact [email protected].

Anti-Hu CD64 Purified

Clone: 10.1
Format: Purified
Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
References & Citations: *Devaraj S, Du Clos TW, Jialal I: Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005 Jul25(7):1359-63., URL: https://www.ncbi.nlm.nih.gov/pubmed/15860734,*Devaraj S, Davis B, Simon SI, Jialal I: CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol. 2006 Sep291(3):H1170-6., URL: https://www.ncbi.nlm.nih.gov/pubmed/16603696,*Jayaram Y, Buckle AM, Hogg N: The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma. Clin Exp Immunol. 1989 Mar75(3):414-20., URL: https://www.ncbi.nlm.nih.gov/pubmed/2495203,*Ohradanova-Repic A, Machacek C, Charvet C, Lager F, Le Roux D, Platzer R, Leksa V, Mitulovic G, Burkard TR, Zlabinger GJ, Fischer MB, Feuillet V, Renault G, Blüml S, Benko M, Suchanek M, Huppa JB, Matsuyama T, Cavaco-Paulo A, Bismuth G, Stockinger H: Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances. Front Immunol. 2018 Apr 279:852., URL: https://www.ncbi.nlm.nih.gov/pubmed/29780382 ,*Hashimoto S, Yamada M, Motoyoshi K, Akagawa KS: Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood. 1997 Jan 189(1):315-21., URL: https://www.ncbi.nlm.nih.gov/pubmed/8978307,*Fadlon E, Vordermeier S, Pearson TC, Mire-Sluis AR, Dumonde DC, Phillips J, Fishlock K, Brown KA: Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood. 1998 Jan 191(1):266-74., URL: https://www.ncbi.nlm.nih.gov/pubmed/9414294,*Brichard B, Varis I, Latinne D, Deneys V, de Bruyere M, Leveugle P, Cornu G: Intracellular cytokine profile of cord and adult blood monocytes. Bone Marrow Transplant. 2001 May27(10):1081-6., URL: https://www.ncbi.nlm.nih.gov/pubmed/11438825,*Sánchez-Torres C, García-Romo GS, Cornejo-Cortés MA, Rivas-Carvalho A, Sánchez-Schmitz G: CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. Int Immunol. 2001 Dec13(12):1571-81., URL: https://www.ncbi.nlm.nih.gov/pubmed/11717198,*Beekman JM, Bakema JE, van der Linden J, Tops B, Hinten M, van Vugt M, van de Winkel JG, Leusen JH: Modulation of FcgammaRI (CD64) ligand binding by blocking peptides of periplakin. J Biol Chem. 2004 Aug 6279(32):33875-81., URL: https://www.ncbi.nlm.nih.gov/pubmed/15161926,*Roura-Mir C, Wang L, Cheng TY, Matsunaga I, Dascher CC, Peng SL, Fenton MJ, Kirschning C, Moody DB: Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J Immunol. 2005 Aug 1175(3):1758-66., URL: https://www.ncbi.nlm.nih.gov/pubmed/16034117,*Dougherty GJ, Selvendran Y, Murdoch S, Palmer DG, Hogg N: The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur J Immunol. 1987 Oct17(10):1453-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/3500057,*Sutherland DR, Richards SJ, Ortiz F, Nayyar R, Benko M, Marinov I, Illingworth A: CD71 improves delineation of PNH type III, PNH type II, and normal immature RBCS in patients with paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom. 2019 Nov 8. doi: 10.1002/cyto.b.21853. , URL: https://www.ncbi.nlm.nih.gov/pubmed/31705743,*Sutherland DR, Illingworth A, Marinov I, Ortiz F, Andreasen J, Payne D, Wallace PK, Keeney M: ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing. Cytometry B Clin Cytom. 2018 Jan94(1):23-48., URL: https://www.ncbi.nlm.nih.gov/pubmed/29236353,

Complementary Product Range

Our range of products, including Anti-Hu CD64 Purified, falls within the same field of application and can be used across various research projects. These products are carefully selected for their high performance and reliability, supporting the diverse needs of modern laboratories. Whether for ongoing studies or future experiments, they are designed to help researchers achieve their scientific goals. Here are some related products that may be of interest for similar or future applications:

Each item in our collection, is tested for precision and quality, ensuring dependable solutions for your research. As we continue to incorporate the latest advancements, Gentaur ensures that our product range remains relevant and versatile, providing you with the tools needed for both current and future projects.

Find us on

Cat	Name
11-644-C100	Anti-Hu CD64 Purified
11-644-C025	Anti-Hu CD64 Purified
12-644-C100	Anti-Hu CD64 Purified Low Endotoxin
1P-644-T025	Anti-Hu CD64 PE
1A-644-T100	Anti-Hu CD64 APC
1B-644-C100	Anti-Hu CD64 Biotin
1B-644-C025	Anti-Hu CD64 Biotin
1P-644-T100	Anti-Hu CD64 PE
1A-644-T025	Anti-Hu CD64 APC
1F-644-T025	Anti-Hu CD64 FITC